Medanta Q2 FY2027 slides: 60% EBITDA growth, Noida breakeven

Global Health Limited's Medanta hospital chain reported impressive financial results for the second quarter and first half of the fiscal year 2027, showcasing robust revenue growth and operational efficiency. The company's investor presentation revealed a 34% year-over-year increase in revenue, reaching INR 14,690 million, while operating EBITDA surged by 60% to INR 3,701 million.

Medanta's Noida facility, which opened just one year prior, achieved EBITDA breakeven, a significant milestone in the hospital's expansion strategy. The company's stock rose 5.63% following the earnings call, trading near the upper end of its 52-week range as investors showed confidence in Medanta's growth trajectory. Revenue from operations grew by 33.6% from INR 10,993 million in Q2 FY2026, while profit after tax increased by 38.3% to INR 2,191 million, with margins expanding to 14.9% from 14.4%.

The company's success was driven by a 29.5% rise in in-patient volumes to 66,000 and a 37.9% surge in out-patient volumes to 1,229,000, with average revenue per patient increasing by 2.7%. The Noida hospital's achievement of EBITDA breakeven in its first year of operation underscores Medanta's operational prowess and the scalability of its healthcare delivery model.